CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $16,000 | -94.1% | 3,100 | -92.8% | 0.00% | -93.5% |
| Q2 2021 | $273,000 | -59.3% | 43,200 | -50.2% | 0.03% | -56.3% |
| Q1 2021 | $671,000 | +100.3% | 86,800 | +69.5% | 0.07% | +115.2% |
| Q4 2020 | $335,000 | -15.2% | 51,199 | -13.8% | 0.03% | -34.0% |
| Q3 2020 | $395,000 | -32.8% | 59,400 | -15.8% | 0.05% | -36.7% |
| Q2 2020 | $588,000 | +163.7% | 70,559 | +623.8% | 0.08% | +1875.0% |
| Q2 2018 | $223,000 | -49.3% | 9,748 | -37.0% | 0.00% | -50.0% |
| Q1 2018 | $440,000 | +10.0% | 15,466 | -18.4% | 0.01% | 0.0% |
| Q4 2017 | $400,000 | +158.1% | 18,948 | +122.6% | 0.01% | +166.7% |
| Q3 2017 | $155,000 | -3.1% | 8,511 | -17.7% | 0.00% | 0.0% |
| Q2 2017 | $160,000 | – | 10,346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |